Vimarsana
Biggest News Aggregation in the World

Page 3 - Danforth Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Danforth Advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Danforth Advisors Today - Breaking & Trending Today

Bluebird CFO resigns ahead of gene therapy launch - Vimarsana News

Bluebird CFO resigns ahead of gene therapy launch

BioPharma

Cambridge Isotope Laboratories Appoints John Bakke as Vice President of Finance - Vimarsana News

Cambridge Isotope Laboratories Appoints John Bakke as Vice President of Finance

John Bakke, VP of Finance TEWKSBURY, Mass. - August 15, 2022 - (Newswire.com) Cambridge Isotope Laboratories, Inc., the world's leading manufacturer of stable isotopes and stable isotope...

RenovoRx Appoints James Ahlers as Chief Financial Officer - Vimarsana News

RenovoRx Appoints James Ahlers as Chief Financial Officer

19.07.2022 - RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is announcing the appointment of James Ahlers as Chief Financial Officer (CFO), effective July 15, 2022, and the addition of Ronald B. Kocak ... Seite 1

Julianne Averill and Kristen Richardson Join Anji Pharma to Ready Company for Next Stage of Growth - Vimarsana News

Julianne Averill and Kristen Richardson Join Anji Pharma to Ready Company for Next Stage of Growth

- Key C-suite appointments provide fiscal and culture leadership as company expandsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Anji Pharma, an emerging global medicines company, today announced an expanded leadership team with the appointments of Julianne Averill as Chief Financial Officer and Kristen Richardson as Chief Peo...

Capital Southwest Announces Financial Results for Third - Vimarsana News

Capital Southwest Announces Financial Results for Third

CSWC Reports Pre-Tax Net Investment Income of $0.51 Per Share for Quarter Ended December 31, 2021...